Cardiovascular Revascularization Medicine
including Molecular Interventions
Please note that due to a system merger our fulfilment system will be down beginning September 22nd with an anticipated date to begin shipping orders October 10th. We would like to apologize for any inconvenience by offering you a special 20% discount on select products. Please use Promotional Code 12760. Click here for promotion details.
Cardiovascular Revascularization Medicine (CRM) is an international and multidisciplinary journal that publishes original laboratory and clinical investigations related to revascularization therapies in cardiovascular medicine.
Cardiovascular Revascularization Medicine publishes articles related to preclinical work and molecular interventions, including angiogenesis, cell therapy, pharmacological interventions, restenosis management; and prevention, including experiments conducted in human subjects, in laboratory animals, and in vitro. Specific areas of interest include percutaneous angioplasty in coronary and peripheral arteries, intervention in structural heart disease, cardiovascular surgery, congenital heart disease, coronary heart disease, epidemiology, genetics, health services and outcomes research, invasive imaging, molecular cardiology, preventive cardiology, and vascular medicine.
Cardiovascular Revascularization Medicine will consider all articles describing clinical trials and translational research (ie, those that unite the clinic with the laboratory). The Journal publishes original articles, rapid communications, reviews, technical notes, teaching editorials, and special features. Original articles that address any aspect of cardiovascular revascularization medicine are invited. Letters to the Editor and interesting images are encouraged.View all Cardiology titles
- Imprint: ELSEVIER
- ISSN: 15538389